Governor Phil Murphy

Twitter Facebook YouTube Instagram Snapchat

Governor Murphy Hails Teligent’s Investment in New Jersey’s Innovation Economy


BUENA – Governor Phil Murphy today praised the multi-million-dollar investment and expansion of Teligent, Inc., during ribbon-cutting ceremonies for the Buena-based specialty generic pharmaceutical firm.
“Today is a great day for Atlantic County, all of South Jersey and, indeed, our entire state. It’s also a very good day for our efforts to expand the innovation economy here in New Jersey,” said Governor Murphy. “Groundbreaking pharmaceutical research has been one of our core economic pillars for a long time and we are committed to ensuring it remains so for a long time to come.”
“As more and more companies see what Teligent sees – our highly skilled workforce, our proximity to global markets, and our New Jersey values – they will come to the same conclusion Teligent did: There’s no better place than New Jersey to call home,” the Governor added.
“Teligent’s major plant expansion is the largest project of its type to ever come to Buena Vista Township and Governor Murphy’s attendance is a clear sign of the importance of bringing new business opportunities to all of New Jersey,” said Buena Vista Township Mayor Chuck Chiarello.
“This facility opening is an important milestone for our company, and recognizes the great achievements of our team over the last two years. We look forward to receiving the FDA for our readiness inspection later this year, so we can manufacture high-quality, affordable sterile injectable medicines for hospitals around the country,”said Jason Grenfell-Gardner, President and CEO of Teligent. “We are grateful to Mayor Chiarello and the local community, as well as so many Atlantic County and State officials, who have supported our journey from vision to reality.”
Teligent’s new $60 million facility expansion is a 200 percent increase in facility space by 75,000 square feet to 110,000 square feet.  The expansion encompasses state-of-the-art manufacturing capabilities to produce sterile injectable and topical pharmaceutical products that will be sold to hospitals and pharmacies in the United States and Canada.
In addition, the expansion has nearly doubled employment to 225 at the Buena facility, bringing with it new positions in advanced engineering and technology as well as entry-level and administrative positions.
Teligent was founded in 1977 as IGI Laboratories with a commitment to developing, manufacturing and marketing topical, injectable, complex and ophthalmic generic pharmaceutical products. It has been headquartered in Atlantic County since its founding and has locations in Iselin, Toronto, and Tallinn.